Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EmpiraMed logo — Virtual Clinical Study Platform to Generate Real World Evide...

EmpiraMed

Virtual Clinical Study Platform to Generate Real World Evidence for the Life Science Industry

Founded 2011 United States Maynard, United States 8 employees Biotechnology, Life Sciences +1

General Information

Company Name EmpiraMed
Founded Year 2011
Location United States Maynard, United States
Employees 8
Industries Biotechnology, Life Sciences, Medical Devices
Social

BounceWatch is an independent company data service, not affiliated with EmpiraMed. To contact EmpiraMed, visit empiramed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About EmpiraMed

EmpiraMed: EmpiraMed is a digital clinical technology company founded in 2011. The company's slogan "Virtual Clinical Study Platform to Generate Real World Evidence for the Life Science Industry" encapsulates its primary focus. With a headquarters in the United States, EmpiraMed operates within the Biotechnology, Life Sciences, and Medical Devices industries. The company specializes in capturing Real World Evidence in Clinical Trials and Post Market Studies through its flexible and configurable plug and play modules in a unified cloud environment. EmpiraMed's technology allows for the orchestration and operationalization of any protocol to facilitate the quick deployment of site-based, site-less, or hybrid clinical trials specific to various therapeutic areas. The company's approach includes unique participant-centered gamification and incentivization, resulting in increased participation and retention rates that are over 3X the industry standard, thereby maximizing project success. Currently, there is no available information regarding EmpiraMed's last investment or the involved investors. As a potential investment opportunity, EmpiraMed's innovative approach to decentralized and virtual clinical trials, coupled with its focus on Real World Evidence generation, presents an intriguing prospect for venture capital firms seeking to engage with disruptive technological advancements in the life sciences sector. Overall, EmpiraMed's positioning within the digital clinical technology landscape and its capability to address the evolving needs of clinical trials could make it an attractive investment opportunity for venture capital entities.

Taxonomy: Virtual Clinical Study Platform, Real World Evidence, Digital Clinical Technology, Decentralized Clinical Trials, Patient Engagement, Clinical Study Execution, Post-Market Studies, Pharmaceutical Research, Rare Disease Studies, Patient Reported Outcomes, Comparative Effectiveness Research, Mobile Device Independence, Quality Improvement Intervention Programs, Registries

No funding data available for EmpiraMed yet.

EmpiraMed Alternatives & Competitors

EmpiraMed vs
Human Data Sciences
Human Data Sciences United Kingdom

Experts in real-world evidence generation. Delivering intelligence in minutes and studies in days —...

Venture round
38 employees
Biotechnology, Health Care
EmpiraMed vs
Rubix LS
Rubix LS United States

We're the Health Outcomes Architect Company.

Seed
10 employees
Biopharma, Biotechnology

FAQ About EmpiraMed

Virtual Clinical Study Platform to Generate Real World Evidence for the Life Science Industry
EmpiraMed was founded in 2011.
EmpiraMed is headquartered in Maynard, United States.
EmpiraMed operates in Biotechnology, Life Sciences and Medical Devices. Its work centres on Virtual Clinical Study Platform, Real World Evidence, Digital Clinical Technology and Decentralized Clinical Trials.
EmpiraMed has approximately 8 employees.
Top alternatives and competitors to EmpiraMed include Human Data Sciences, Rubix LS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EmpiraMed and Human Data Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EmpiraMed, https://bouncewatch.com/company/empiramed, updated 3 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes